Parizad Torabi-Parizi, M.D.

Investigator

Critical Care Medicine Department

NIH Clinical Center

Building 10, Room 2C145
10 Center Drive
Bethesda, MD 20892

301-496-9320

torabiparizip@cc.nih.gov

Research Topics

Dr. Parizad Torabi-Parizi is interested in understanding mechanisms of lung injury secondary to pulmonary infections by elucidating the nature and extent of the host's immune response.

Honors and Awards

  • Clinical Center CEO Award, 2018
  • Clinical Center CEO Award, 2017
  • Clinical Center Director's Award, 2015
  • NIH Director's Award, 2015
  • Clinical Center Director's Award, 2014
  • NIH Director's Award, 2012
  • NIAID Merit Award, 2011

Biography

Dr. Torabi-Parizi earned her undergraduate degree and degree in Medicine from Emory University. She completed her internship and residency training in Internal Medicine at the Johns Hopkins Hospital Osler Training Program.

Dr. Torabi-Parizi completed her fellowship training in Critical Care Medicine at the NIH and was subsequently appointed as Staff Clinician in the Critical Care Medicine Department at the NIH in 2011. She became an Assistant Clinical Investigator in the Critical Care Medicine Department in 2013 and is now a Tenure-Track Investigator. She also chairs the Clinical Center CPR committee.

She has had a long-standing interest in innate immune cell and effector T cell behavior in peripheral tissues, mechanisms regulating this behavior, and possible interventions that might modulate effector responses to improve host outcomes, in the context of critical illness.

Selected Publications

  1. Curran CS, Bolig T, Torabi-Parizi P. Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection. Am J Respir Crit Care Med. 2018;197(6):708-727.

  2. Torabi-Parizi P. Critical care management of two patients with Ebola: a biocontainment unit demystified. Crit Care Med. 2015;43(6):1326-7.

  3. Torabi-Parizi P, Davey RT Jr, Suffredini AF, Chertow DS. Ethical and practical considerations in providing critical care to patients with Ebola virus disease. Chest. 2015;147(6):1460-1466.

  4. Gerner MY, Torabi-Parizi P, Germain RN. Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens. Immunity. 2015;42(1):172-85.

  5. Subramanian N, Torabi-Parizi P, Gottschalk RA, Germain RN, Dutta B. Network representations of immune system complexity. Wiley Interdiscip Rev Syst Biol Med. 2015;7(1):13-38.


This page was last updated on February 6th, 2020